A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant FSH preparations Gonal-F and Puregon

Human Reproduction

Volumn 15, Issue 9, 2000, Pages 1898-1902

  Horsman, G ^a   Talbot, J A ^a   McLoughlin, J D ^a   Lambert, A ^b   Robertson, W R ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

FSH; Glycoforms; Gonal F; Puregon; rFSH

Indexed keywords

9F073; B 3228; RECOMBINANT FOLLITROPIN;

ANIMAL CELL; ARTICLE; CARBOHYDRATE ANALYSIS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG POTENCY; IMMUNOPOTENTIATION; IN VITRO STUDY; NONHUMAN; RAT; SERTOLI CELL;

EID: 0033811713     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.9.1898     Document Type: Article

References (33)

1. Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state
2. Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of the asparagine-linked oligosaccharides on lupotropin, follitropin and thyrotropin
3. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): Results of a randomized comparative study in women undergoing assisted reproductive techniques
4. Heterogeneity of rat FSH by chromatofocusing: Studies on serum FSH released in vitro and metabolic clearance rates of its various forms
5. A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer
6. Heterogeneity of follicle stimulating hormone: Control and physiological function
7. Fractionation of asparagine-linked oligosaccharides by serial lectin-agarose affinity chromatography. A rapid, sensitive, and specific technique
8. Naturally occurring antihormones: Secretion of FSH antagonists by women treated with a GnRH analog
9. Structure-function relationship of recombinant follicle stimulating hormone (Puregon)
10. Asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Part I.
11. Asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Part II
12. Internal carbohydrate complexity of the oligosaccharide chains of recombinant human follicle stimulating hormone (Puregon, Org 32489): A comparison with Metrodin and Metrodin-HP
13. In-vitro biopotency of two glycoform mixtures of differing acidity derived from recombinant FSH measured using a human granulosa-lutein cell bioassay
14. A physico-chemical, immunological and biological comparison of two clinical batches of the recombinant FSH preparation. Gonal-F (1999)
15. Genetic engineering of human FSH (Gonal-F)
16. In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP
17. Gonadotrophin heterogeneity and biopotency: Implications for assisted reproduction
18. Prediction of the in vivo biological activity of human recombinant follicle stimulating hormone using quantitative isoelectric focusing
19. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon®)
20. Do immunoassays differentially detect different acidity glycoforms of FSH?
21. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization
22. Modulation of follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis
23. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization
24. Variability in the immunoreactive and bioactive follicle stimulating hormone content of human urinary menopausal gonadotrophin preparations
25. Physicochemical characterization of recombinant follicle stimulating hormone
26. A biological and physico-chemical comparison of two batches of the recombinant FSH preparation Puregon (1999)
27. Follicle-stimulating isohormones: Characterization and physiological relevance
28. A sensitive and specific in-vitro bioassay method for the measurement of follicle-stimulating hormone-activity
29. Isoforms of recombinant follicle-stimulating hormone: Comparison of effects on murine follicular development in vitro
30. More basic forms of both human follicle-stimulating hormone and luteinising hormone at mid-cycle compared with the follicular and luteal phase
31. 17β-Oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormones after menopause
32. More basic isoforms of serum gonadotrophins during gonadotrophin-releasing hormone agonist therapy in pubertal children
33. Dynamics of basal and gonadotrophin-releasing hormone-releasable serum follicle-stimulating-hormone charge distribution throughout the human menstrual cycle